Financial News
Cybin Inc (NY: CYBN )
0.2680
+0.0007
(+0.26%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Cybin Inc
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_16.jpg?width=720)
Cybin (NEO: CYBN) (NYSE American: CYBN) Reports Adelia Milestone
February 22, 2022
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_12.png?width=720)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1135.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220218005087/en/1084589/5/Cybin_Primary_Logo_Blue_Final.jpg)
Cybin Announces Additional Adelia Milestone Achievement
February 18, 2022
From Cybin Inc.
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_11.png?width=720)
Psychedelic Stock Gainers And Losers From February 17, 2022
February 17, 2022
Via Benzinga
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/photo-1484627147104-f5197bcd6651.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/deepak_chopra_2013.jpeg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_9.png?width=720)
![](https://mms.businesswire.com/media/20220215006074/en/1084589/5/Cybin_Primary_Logo_Blue_Final.jpg)
Cybin to Participate in Aegis Virtual Conference on February 24, 2022
February 15, 2022
From Cybin Inc.
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/screenshot_2022-02-15_at_11.02.35_pm.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/psychedelic_image_8.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mathew-schwartz-rwrby8j9gpo-unsplash4.jpg?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/psyched_cover_ver_2_15.jpg?width=720)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_7.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/photo-1621490495897-a8508b0d085c.jpeg?width=1200&height=800&fit=crop)
Cybin (NEO: CYBN) (NYSE American: CYBN) Granted US Patent Covering Lead Proprietary Compound
February 10, 2022
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20220210005341/en/1084589/5/Cybin_Primary_Logo_Blue_Final.jpg)
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_5.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/1_8_2.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.